Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer Grant US-11951166-B2 United States of America 09 Apr 2024
Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treating cancer Grant US-11517622-B2 United States of America 06 Dec 2022
Use of chloroquine and clemizole compounds for treatment of inflammatory and cancerous… Grant US-10688083-B2 United States of America 23 Jun 2020